Perceptive Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,663	Closed	-$726K	–	156
2021 Q4	$726K	Hold	4,663	–	–	0.01%	137
2021 Q3	$934K	Hold	4,663	–	–	0.01%	133
2021 Q2	$1.19M	Hold	4,663	–	–	0.02%	141
2021 Q1	$1.24M	Hold	4,663	–	–	0.02%	128
2020 Q4	$1.72M	Hold	4,663	–	–	0.02%	129
2020 Q3	$1.14M	Hold	4,663	–	–	0.02%	113
2020 Q2	$1.34M	Hold	4,663	–	–	0.02%	106
2020 Q1	$951K	Hold	4,663	–	–	0.02%	96
2019 Q4	$2.08M	Hold	4,663	–	–	0.04%	86
2019 Q3	$1.43M	Hold	4,663	–	–	0.04%	83
2019 Q2	$1.48M	Hold	4,663	–	–	0.03%	87
2019 Q1	$1.96M	Hold	4,663	–	–	0.06%	75
2018 Q4	$1.42M	Sell	4,663 -593	-11%	-$181K	0.05%	77
2018 Q3	$1.89M	Hold	5,256	–	–	0.05%	85
2018 Q2	$1.92M	Hold	5,256	–	–	0.05%	88
2018 Q1	$1.55M	Hold	5,256	–	–	0.04%	94
2017 Q4	$2.2M	Hold	5,256	–	–	0.07%	89
2017 Q3	$1.73M	Hold	5,256	–	–	0.07%	93
2017 Q2	$1.25M	Hold	5,256	–	–	0.06%	85
2017 Q1	$1.81M	Hold	5,256	–	–	0.1%	86
2016 Q4	$1.84M	Buy	5,256 +925	+21%	+$323K	0.13%	83
2016 Q3	$1.74M	Buy	4,331 +834	+24%	+$335K	0.11%	88
2016 Q2	$2.08M	Hold	3,497	–	–	0.14%	79
2016 Q1	$1.76M	Buy	+3,497	New	+$1.76M	0.15%	84
2015 Q2	–	Hold	0	–	–	–	184
2015 Q1	–	Hold	0	–	–	–	169